Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
roche
boston
boston blog main
boston top stories
clinical trials
deals
europe top stories
fda
genentech
san francisco top stories
avapritinib
billy dunn
biogen
biopharma
blueprint medicines
cstone pharmaceuticals
drug prices
drug pricing
duchenne
eli lilly
europe blog main
european medicines agency
evrysdi
fisogatinib
flatiron health
gene therapy
hepatocellular carcinoma
investing
ionis pharmaceuticals
jeff albers
licensing
m&a
medullary thyroid cancer
muscular dystrophy
national
new york top stories
What
fda
4
×
roche
4
×
approval
drug
medicine
swiss
therapy
approved
approves
atrophy
available
betting
billion
biopharma
blueprint
cancer
candidate
collectively
come
commercial
coronavirus
currently
daily
deal
device
duchenne
evrysdi
fisher
friday
gene
giant
green
historic
home
intended
lights
liquid
maker
marketing
medical
Language
unset
Current search:
roche
×
fda
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@wired.com
4 years ago
FDA Approves the First Commercial Coronavirus Tests in the US
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal